WASHINGTON, D.C. — The following statement was issued by Sarah Kaminer Bourland, the legislative director of Patients For Affordable Drugs Now, following the House Judiciary Committee’s markup of four bills that would crack down on the drug industry’s patent abuses and promote competition in the pharmaceutical market:

“Drug companies are abusing our patent system to protect their profits and extend monopolies beyond what the law intended. These anti-competitive tactics undermine innovation and force patients to pay higher prices for longer periods of time. 

“While Medicare negotiation is the cornerstone of comprehensive drug pricing reform, we applaud the House Judiciary Committee for advancing these bipartisan bills that are critical to restoring balance in our system and curbing practices such as product hopping, pay-for-delay deals, frivolous citizen petitions, and patent thicketing. Patients deserve both Medicare negotiation and patent reform, and we look forward to making sure they’re passed into law this year.”